cyc 202 has been researched along with laq824 in 1 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (laq824) | Trials (laq824) | Recent Studies (post-2010) (laq824) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 70 | 1 | 19 |
| Protein | Taxonomy | cyc 202 (IC50) | laq824 (IC50) |
|---|---|---|---|
| Histone deacetylase 3 | Homo sapiens (human) | 0.0607 | |
| Histone deacetylase 4 | Homo sapiens (human) | 0.0848 | |
| Histone deacetylase 1 | Homo sapiens (human) | 0.0512 | |
| Histone deacetylase 7 | Homo sapiens (human) | 0.3987 | |
| Histone deacetylase 2 | Homo sapiens (human) | 0.0506 | |
| Polyamine deacetylase HDAC10 | Homo sapiens (human) | 0.0309 | |
| Histone deacetylase 11 | Homo sapiens (human) | 0.0303 | |
| Histone deacetylase 8 | Homo sapiens (human) | 0.0974 | |
| Histone deacetylase 6 | Homo sapiens (human) | 0.0545 | |
| Histone deacetylase 9 | Homo sapiens (human) | 0.0308 | |
| Histone deacetylase 5 | Homo sapiens (human) | 0.0569 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almenara, JA; Atadja, P; Craig, R; Dent, P; Grant, S; Maggio, SC; Rosato, RR; Vrana, J | 1 |
1 other study(ies) available for cyc 202 and laq824
| Article | Year |
|---|---|
Potentiation of the lethality of the histone deacetylase inhibitor LAQ824 by the cyclin-dependent kinase inhibitor roscovitine in human leukemia cells.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Inducing Factor; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Cytochromes c; Cytosol; Down-Regulation; Enzyme Inhibitors; Flow Cytometry; Histone Deacetylase Inhibitors; HL-60 Cells; Humans; Hydroxamic Acids; Jurkat Cells; Leukemia; Membrane Potentials; Mitochondria; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Protein Conformation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Purines; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Roscovitine; Time Factors; U937 Cells; X-Linked Inhibitor of Apoptosis Protein | 2005 |